APAaron J. Polichnowski

Aaron J. Polichnowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aaron J. Polichnowski has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Geoffrey A. Williamson

    From the Research and Development Service, Edward Hines Jr. VA Hospital, Hines, IL (A.J.P.); Department of Medicine, (A.J.P.) and Department of Pathology (M.P.), Loyola University-Chicago, Maywood, IL; and Department of Electrical and Computer Engineering, Illinois Institute of Technology, Chicago (J.L., G.A.W.).

    2 shared publications
  • Jianrui Long

    From the Research and Development Service, Edward Hines Jr. VA Hospital, Hines, IL (A.J.P.); Department of Medicine, (A.J.P.) and Department of Pathology (M.P.), Loyola University-Chicago, Maywood, IL; and Department of Electrical and Computer Engineering, Illinois Institute of Technology, Chicago (J.L., G.A.W.).

    2 shared publications
  • Alan Le Mercier

    1 shared publication
  • Amelia Focaccio

    1 shared publication
  • Anil K. Bidani

    Hines Veterans Affairs Hospital and Department of Medicine Loyola University, Maywood, Illinois

    1 shared publication
  • Anil K. Bidani

    Division of Nephrology, Department of Medicine, Loyola University Medical Center and

    1 shared publication

Latest Publications

  • Abstract P378: Dahl Salt-Sensitive Rats Exhibit Aberrant Renal Hemodynamic Responses to a High Salt Diet and Salt-Sensitive Hypertension as Compared to Consomic SS.BN1 Rats

    by Aaron J Polichnowski, Jacqueline Potter, Shannon Allen, Rhesa Dykes, Michelle Duffourc, Geoffrey A Williamson

    Altered renal vascular responses to a high salt diet have been proposed to contribute to salt-sensitive (SS) hypertension. The goals of this study were to assess: 1) SS hypertension and renal injury in Dahl SS vs. Brown-Norway (BN) and consomic SS.BN1 rats and 2) renal hemodynamics in conscious SS vs. SS.BN1 rats during consumption of a low and high salt diet. Systolic BP (24 hrs/day via telemetry), proteinuria and renal injury were assessed in 10 week old SS (n=9), BN (n=8) and SS.BN1 (n=8) rats during a 0.4% NaCl diet and for 3 weeks during a 4.0% NaCl diet. On a 0.4% NaCl diet, BP was different (P<0.05) among SS, BN and SS.BN1 rats (160±1 vs. 115±2 vs. 141±2 mmHg) while proteinuria was higher (P<0.05) in SS vs. BN and SS.BN1 rats (87±14 vs. 22±3 and 30±5 mg/day). A 4% NaCl diet exacerbated differences (P<0.05) in BP (188±3 vs. 122±2 vs. 150±1 mmHg) and proteinuria (259±29 vs. 29±5 vs. 68±15 mg/day) between SS vs. BN and SS.BN1 rats. Abundant uromodulin (UMOD) positive protein casts were only observed in SS rats. Interestingly, strikingly low levels of UMOD, located on chromosome 1, were found in the urine of SS vs. BN and SS.BN1 rats at baseline. Mean arterial BP (MAP, mmHg, via telemetry), renal vascular resistance (RVR, mmHg/ml/min) and renal blood flow (RBF, ml/min, via Transonic flow probe) were assessed in conscious 10 week old SS (n=5) vs. SS.BN1 (n=5) rats for 2-3 hrs/day over 3 days of 0.4% NaCl feeding and over days 3-7 of 4.0% NaCl feeding. While MAP was higher during a 0.4% NaCl diet in SS vs. SS.BN1 rats (137±3 vs. 121±3), interestingly, RVR was lower (16±2 vs. 20±2, P<0.05) and RBF higher (9±1 vs. 6±1, P<0.05) in SS vs. SS.BN1 rats. During 4.0% NaCl feeding, RVR decreased (17±2, P<0.05), RBF increased (8±1, P<0.05) and MAP remained unchanged (122±3) in SS.BN1 rats whereas RVR increased (19±3, P<0.05), RBF remained unchanged (8±1) and MAP increased (146±4, P<0.05) in SS rats. In conclusion, SS hypertension is abolished in SS.BN1 rats. Dahl SS rats exhibit an unexpected low RVR and high RBF when fed a 0.4% NaCl diet vs. SS.BN1 rats. Yet, SS rats display an impaired ability to lower RVR during a high salt diet as compared to SS.BN1 rats. These data warrant future investigations into the role that UMOD may play in altering renal hemodynamics, SS hypertension and CKD in Dahl SS rats.

  • Determinants of Hypertensive Renal Disease and Its Progression

    by Karen A. Griffin, Aaron J Polichnowski, Anil K. Bidani

  • Open Access

    Progression of Chronic Kidney Disease After Acute Kidney Injury

    by Maria Picken, Jianrui Long, Geoffrey A. Williamson, Aaron J. Polichnowski, Carlo Briguori, Gabriella Visconti, Natalia V. Rivera, Amelia Focaccio, Bruno Golia, Rosalia Giannone, et al.

    The relative contribution of self-perpetuating versus hemodynamic-induced fibrosis to the progression of chronic kidney disease (CKD) after acute kidney injury (AKI) is unclear. In the present study, male Sprague-Dawley rats underwent right uninephrectomy and were instrumented with a blood pressure radiotelemeter. Two weeks later, separate groups of rats were subjected to 40 minutes renal ischemia–reperfusion or sham surgery and followed up for 4 or 16 weeks to determine the extent to which glomerulosclerosis and tubulointerstitial fibrosis as a result of the AKI–CKD transition (ie, at 4 weeks post AKI) change over time during the progression of CKD (ie, at 16 weeks post AKI). On average, tubulointerstitial fibrosis was ≈3-fold lower ( P P <0.05) at 16 versus 4 weeks post AKI. At 16 weeks post AKI, marked tubulointerstitial fibrosis was only observed in rats exhibiting marked glomerulosclerosis, proteinuria, and kidney hypertrophy consistent with a hemodynamic pathogenesis of renal injury. Moreover, quantitative analysis between blood pressure and renal injury revealed a clear and modest blood pressure threshold (average 16-week systolic blood pressure of ≈127 mm Hg) for the development of glomerulosclerosis. In summary, modest levels of blood pressure may be playing a substantial role in the progression of renal disease after AKI in settings of preexisting CKD associated with 50% loss of renal mass. In contrast, these data do not support a major role of self-perpetuating tubulointerstitial fibrosis in the progression CKD after AKI in such settings.


  • Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension

    by Aaron J. Polichnowski, Karen A. Griffin, Maria M. Picken, Hector Licea-Vargas, Jianrui Long, Geoffrey A. Williamson, Anil K. Bidani

    ANG II is thought to increase the susceptibility to hypertension-induced renal disease (HIRD) via blood pressure (BP)-dependent and BP-independent pathways; however, the quantitative relationships between BP and HIRD have not been examined in ANG II-infused hypertensive rats. We compared the relationship between radiotelemetrically measured BP and HIRD in Sprague-Dawley rats (Harlan) chronically administered ANG II (300–500 ng·kg−1·min−1, n = 19) for 4 wk versus another commonly employed pharmacological model of hypertension induced by the chronic administration of Nω-nitro-l-arginine methyl ester (l-NAME, 50 mg·kg−1·min−1, n = 23). Despite the significantly higher average systolic BP associated with ANG II (191.1 ± 3.2 mmHg) versus l-NAME (179.9 ± 2.5 mmHg) administration, the level of HIRD was very modest in the ANG II versus l-NAME model as evidenced by significantly less glomerular injury (6.6 ± 1.3% vs. 11.3 ± 1.5%, respectively), tubulointerstitial injury (0.3 ± 0.1 vs. 0.7 ± 0.1 injury score, respectively), proteinuria (66.3 ± 10.0 vs. 117.5 ± 10.1 mg/day, respectively), and serum creatinine levels (0.5 ± 0.04 vs. 0.9 ± 0.07 mg/dl, respectively). Given that HIRD severity is expected to be a function of renal microvascular BP transmission, BP-renal blood flow (RBF) relationships were examined in additional conscious rats administered ANG II ( n = 7) or l-NAME ( n = 8). Greater renal vasoconstriction was observed during ANG II versus l-NAME administration (41% vs. 23% decrease in RBF from baseline). Moreover, administration of ANG II, but not l-NAME, led to a unique BP-RBF pattern in which the most substantial decreases in RBF were observed during spontaneous increases in BP. We conclude that the hemodynamic effects of ANG II may mediate the strikingly low susceptibility to HIRD in the ANG II-infused model of hypertension in rats.